Health ❯ Public Health ❯ Infectious Diseases ❯ HIV/AIDS
Harnessing aluminum hydroxide alongside a saponin nanoparticle to sustain antigen retention for up to a month, the vaccine primes diverse B cell responses ahead of clinical trials.